VC Funding In 2013: Some Impressive Device Rounds, But Momentum Shifts To Biotech

Medtech start-ups have closed on some impressive venture capital funding rounds so far this year, with the largest investments concentrated in a few “hot” technology areas. But the biotechnology industry garnered far more VC funding in Q2 than did the medical device sector, particularly with regards to early-stage funding.

Medical device start-ups have closed on some impressive venture capital funding rounds so far this year, with the largest investments concentrated in a few “hot” technology areas, including companies with office-based sinus treatments, technologies aimed at obesity, neuromodulation devices, atrial fibrillation technologies, and transcatheter heart valve devices. However, according to the latest report from PricewaterhouseCoopers LLP (PwC) and the National Venture Capital Association (NVCA), the biotechnology industry garnered far more VC funding in Q2 than did the medical device sector, particularly with regards to early-stage funding.

Notable device rounds completed in the first half of the year included a $30 million Series D closed in March...

More from Deals

More from Business